Atlantic Trust »

Halozyme Therapeutics shares owned by Atlantic Trust

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Atlantic Trust from 13F filings

Historical chart of Atlantic Trust investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Atlantic Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Atlantic Trust

Quarter filed Position value Share count Share price at filing
2024-12-31 $164k 3.1k 53.76
2024-09-30 $55M 967k 57.24
2024-06-30 $207k 3.9k 52.55
2024-03-31 $119k 2.9k 41.32
2022-12-31 $1.5M 26k 56.90
2019-09-30 $337k 22k 15.51
2019-06-30 $373k 22k 17.17
2019-03-31 $450k 28k 16.11
2018-12-31 $471k 32k 14.64
2018-09-30 $549k 30k 18.16
2018-06-30 $435k 26k 16.88
2018-03-31 $435k 22k 19.57
2017-12-31 $462k 23k 20.26
2017-09-30 $447k 26k 17.38
2017-06-30 $341k 27k 12.81
2017-03-31 $324k 25k 12.95
2016-12-31 $247k 25k 9.88
2016-09-30 $250k 21k 12.08
2015-12-31 $312k 18k 17.35
2015-09-30 $224k 17k 13.40
2015-06-30 $466k 21k 22.59
2015-03-31 $268k 19k 14.28